Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
 |
New Vision (Kampala) - September 5, 2008
Anthony Bugembe
"We have averted the situation," Dr. Nathan Mugisha, the acting health ministry permanent secretary, said. "One of our suppliers started delivering on Tuesday. We are also expecting a consignment from the Clinton Foundation within 10 days. Very soon this worry that we may run short of ARVs will not still exist," added Mugisha.
According to the ministry's ARV stock status report (June19-August 19), central stores had no stocks for all the ARVs and had placed several orders.
Appearing on Vision Voice's News Maker programme yesterday morning, Mugisha noted that the shortages were not in all ARVs.
"We are experiencing some shortages in one of the drugs we use for second line treatment for adults and syrup formulations for children," he said
People Living with HIV and AIDS only resort to second line treatment after the first one fails or when they react to it.
"We don't have stock outs in the health facilities. We only have stock outs at the national level (stores). So the patients still have medicines but, of course, we need to have enough stock at the national and facility levels to be sure that the patients will not run out of drugs," Mugisha added.
However, some PLHAs told Saturday Vision that the amount of drugs they receive from some ARVs sites had been reduced drastically over the last one month.
The PS said: "I can confidently say the patients still have ARVs and that we are doing our best to ensure that there will be no body without ARVs at any one time. By the time the ARVs that are with the patients are over, we should have enough to restock their prescriptions."
The strategy is to have a drug stock in the national stores to last two to six months to avert a possible crisis in case of delays in procurement, the acting secretary said.
080905
NV080906
Copyright © 2008 - The New Vision. All articles are republished on AEGIS by permission. Material may not be redistributed, posted to any other location, published or used for broadcast without written authorization from Managing Director/Editor-in-chief, The New Vision, P.O. Box 9815, Kampala - Uganda, Tel/fax: 256-41-235221, E-mail: wpike@newvision.co.ug.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .